Task Force III

Anti-microbial resistance

We work towards reducing the use of antibiotics and promoting antibiotic stewardship in aquaculture farming operations and aquafeed production. Our work is guided by the SeaBOS AMR Road Map that provides for responsible antibiotics use in seafood production and support human and animal health.

Task force leaders


  • Work towards reducing the use of antibiotics in aquaculture.

Our aim is to facilitate for and develop solutions for responsible use of antibiotics in seafood production. Antibiotic stewardship in farming is critical to preserve the efficacy of these essential drugs for human and animal health, and also for minimizing risks for people and the environment. Good stewardship is also critical for the reputation of the aquaculture sector, which recently has come under scrutiny following examples of poor practice. SeaBOS should take the lead in the development towards a transparent and responsible aquaculture sector. We are working with industry, academia, and relevant associations to develop science-based solutions for a broad range of aquaculture systems – enabling a Code of Conduct of responsible antibiotic use. When implemented this will reduce use and improve controls on antibiotic stewardship in seafood production. We particularly focus on the reduction and ultimately elimination of the use of antibiotics that are classed as critically important to human health and as such should not be used for animal or seafood treatments. The goal is to help avoid negative impacts on human and animal health and wellbeing which will arise through antimicrobial resistance if certain practices continue.

Our Accomplishments

Commitments progress report

The below table illustrates the member companies' joint steps towards meeting SeaBOS commitments and does not represent individual company results across all topics. Please consult each company's web page and annual reports for details on each company's results.


Work towards reducing the use of antibiotics in aquaculture.

Shared high-resolution data with scientists 6/10
Road-map for reducing antibiotics 10/10

CEO Sponsors

Lead companies

Lead scientific institutions